moiety is a miscoding lesion and may be responsible for the mutagenic and carcinogenic effects of dialkylnitrosamines and related alkylating agents. An important factor in the tissue specificity of these agents is the presence of a repair enzyme which removes 06-alkylguanine from DNA: it has been shown by a number of groups, using different experimental tumour systems, that the principal target tissue is that in which the repair of 06 alkylguanine is least efficient, i.e. the persistence or accumulation of 06-alkylguanine is greatest (Goth & Rajewsky, 1974; Kleihues & Margison, 1974; & Kleihues, 1975; Nicoll et al., 1975; Lawley, 1976; .
In the rat, chronic administration of DEN in the drinking water produces a high incidence of hepatic tumours (IARC, 1978) . Since, compared to other rat tissues, liver has a high capacity for removing 06-ethylguanine from DNA after a single dose of ethylating agents (Goth & Rajewsky, 1974) , it was of interest to examine the effect of a chronic dose schedule of DEN on this excision system and how it might be related to tumour production.
Chemicals. DNA isolation and analysis.-DNA was extracted from the liver by a phenol procedure (Margison et al., 1976) and hydrolysed in GIN HCI at 70°C for 30 min. The hydrolysate was adjusted to pH 2 8 using 01IN NaOH, and 06-ethylguanine was added as a marker. Normal and ethylated purines were separated on columns (85 x 1*5 cm) of Sephadex G-10 eluted with 0-05Ai ammonium formate in 0.2% w/v sodium azide (pH 6.75) at 40 ml/h.
Normal purines were determined spectrophotometrically and ethylated purines by liquid scintillation counting using internal standardization to calculate counting efficiency, and assuming that the specific activities of the ethylated bases were the same as that of the ethyl groups in the [14Cl-DEN.
With the exception of 3-ethyladenine, the elution position of which is known to be pH-dependent (Goth & Rajewsky, 1975) , the elution positions of the various bases were the same as those reported earlier (Goth & Rajewsky, 1975) .
RESULTS
The levels of ethylpurinces found 12 h after administration of [14Cl]-DEN in the liver DNA of rats receiving DEN in the drinking water for a or 1 0 weeks are given in the Table, together wTith data for agematched controls. The levels of 7-ethylguanine and 3-ethyladenine found in the liver DNA of rats given DEN for 5 weeks were higher than in the corresponding control animals. However, the DENpretreated animals were lighter than the controls (mean weights 290 g and 356 g respectively) and the consequently lower liver weight (16 g vs 24 g) means that the actual dose to the liver was higher in the pretreated animals. Changes in the absolute amounts of these bases may also be due to age and/or DEN-induced changes in the capacity of the liver to metabolize DEN to an alkylating species.
The relative amounts of 3-ethyladenine and 7-ethylguanine were only slightly different in the 5-week experiment the 3-ethyladenine: 7-ethylguanine ratio was decreased in DEN-pretreated animals by 6% of the control level. After 10 weeks the levels of 3-ethyladenine and 7-ethylguanine were slightly lower in the DENpretreated animals, but again the ratio was relatively unaffected, that in the pretreated animals being 6% higher than in controls. In contrast to these results, chronic DEN administration was found to have a considerable effect on the levels of o6-ethylguanine which were reduced by about 60% and 90% of the control levels after 5 weeks and 10 weeks of DEN treatment respectively. This is clearly seen in the 06-ethylguanine: 7-ethylguanine ratios, which compensate for overall differences in the extent of alkylation; these ratios were 26% and 7% of the control values after 5 weeks and 10 weeks respectively (Table) . DISCUSSION In the investigation of the mechanism of action of chemical carcinogens, the biochemical and morphological changes in the rat liver during hepatocarcinogenesis by chronic (and acute) administration of dialkylnitrosamines have been subjects of considerable interest (e.g. Takayama et al., 1975) . In the present study we have examined the effect of chronic administration of DEN on the capacity of the rat liver to remove the promutagenic lesion 06-ethylguanine from DNA. There is evidence from a variety of experimental tumour systems that this product is a key factor in the production of tumours by N-nitroso compounds and related alkylating agents (Pegg, 1977; Margison & O'Connor, 1979) . If this hypothesis is correct, it might be expected that chronic DEN administration would inhibit 06-ethylguanine excision and hence extend its persistence in liver DNA. This would increase the chance of a miscoding event taking place during DNA synthesis, which is a step necessary to convert the repairable lesion into a permanent heritable change in DNA.
Because of the high cost of the [14C]_ DEN used, it was not possible to examine the detailed kinetics of loss of 06-ethylguanine from liver DNA. Instead, 06_ ethylguanine in the liver DNA of control and DEN-pretreated rats was determined 12 h after [14C]-DEN administration, which is about 9 h after the peak of DNA alkylation in normal adult rats (Goth & Rajewsky, 1975) . The amounts of alkylated purines in control rats, and the amount of 3-ethyladenine and 7-ethylguanine in DEN-pretreated rats were similar to those found by other groups (Goth & Rajewsky, 1975; Scherer et al., 1977) . However, the levels of 06-ethylguanine were considerably reduced in the animals pretreated with DEN for 5 weeks and even further reduced after 10 weeks of DEN (see Table) . This indicates a specific increase in the capacity of the liver to excise 06-ethylguanine from DNA. The possibility that the initial extent of reaction at the 06-position of guanine might be reduced by chronic pretreatment is unlikely; although the relative amounts of 06-ethylguanine initially produced in DNA are low after low doses of DEN, even at early times after administration (Scherer et al., 1977) , these results now appear to be a consequence only of repair processes and not of a reduced ability to generate personal communication) .
The reduced persistence of 06-ethylguanine in DNA indicates an enhanced repair capacity and would, according to the hypothesis that this lesion is an essential factor in tumour production by alkylating agents, be expected to reduce the probability of malignant transformation (see above). However, the dose schedule used actually induces a high incidence of liver tumours. One possible explanation for this observation is that the repair which is induced may be errorprone. However, the 06-methylguanineexcision system which is induced in E. coli by prolonged exposure to N-methyl-N'-nitro-N-nitrosoguanidine is error-free (Jeggo et al., 1977; Schendel & Robins, 1979) and this may also be true in mammalian cells (R. Montesano, personal communication) .
Another explanation for the production of liver tumours by chronic DEN administration which would allow for an essential role for 06-ethylguanine is that DNA undergoing repair might be a more critical target in tumour initiation. If miscoding lesions were generated by DEN in the single-stranded DNA thought to be produced during excision repair (Roberts, 1978) of damage produced by earlier doses of DEN, this might "force" the cell into abnormal base pairing. The removal from rat liver DNA of 06-methylguanine produced by a single dose of [14C]-DMN has also been found to be enhanced by chronic exposure to DMN (Montesano et al., 1979; G. P. Margison, unpublished) . Similarly, in animals fed on a diet containing AAF, after which a normally subcarcinogenic dose of DMN will induce liver tumours (Becker, 1975) , there was an enhanced removal of 06-methylguan ne produced by the DMN (J. D. Buckley & P. J. O'Connor, personal communication). However, as well as increasing DNA repair, these agents are hepatotoxic, and the situation may therefore be comparable with the effect of partial hepatectomy, which increases the number' of cells in pre-replicative DNA synthesis and sensitizes the liver to tumour production (Craddock, 1976) .
Preliminary results show that chronic DEN treatment enhances the removal of 06-methylguanine produced by [14C]-DMN (G. P. Margison et al., unpublished) . More information on this inductive effect and its role, if any, in tumour induction might be obtained by pretreatment with various other classes of DNA-damaging agents. Furthermore, in these experiments, the repair capacity of whole liver has been measured. There is clearly a need to compare DNA repair in the "preneoplastic" liver nodules with that in the surrounding tissue, and also to extend these observations to the repair of other promutagenic DNA lesions.
